FGF19 Overexpression Combination Unified Study in HCC-19

Clinical trial NCT06978933 · RECRUITING

Trial details

NCT number: NCT06978933
Sponsor: RenJi Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HCC - Hepatocellular Carcinoma

Start date: 2025-04-30
Primary completion: 2026-12-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.